Literature DB >> 31621626

Cerebrovascular pathology presenting as corticobasal syndrome: An autopsy case series of "vascular CBS".

Shunsuke Koga1, Shanu F Roemer1, Koji Kasanuki1, Dennis W Dickson2.   

Abstract

BACKGROUND: The corticobasal syndrome (CBS) is heterogeneous in terms of postmortem neuropathology. While it has been previously studied with antemortem neuroimaging, clinicopathologic features of corticobasal syndrome associated with cerebrovascular pathology (vascular CBS) have yet to be reported.
METHODS: To identify vascular CBS, we searched the database of the CurePSP Brain Bank for patients with a clinical diagnosis of CBS who failed to meet neuropathologic criteria for corticobasal degeneration (CBD) or other neurodegenerative disease processes, but who had significant cerebrovascular pathology. Hemibrains were assessed macroscopically and processed for histological assessment. Medical records were reviewed to characterize clinical features of vascular CBS.
RESULTS: Of 217 patients with an antemortem diagnosis of CBS, we identified three patients with vascular CBS. Multiple infarcts in the watershed regions (frontal lobe and motor cortex), periventricular white matter, thalamus, and basal ganglia were observed in two patients. One patient had no cortical infarcts, but had multiple white matter infarcts and corticospinal tract degeneration. All were clinically thought to have CBS based on progressive asymmetric motor symptoms, including rigidity and apraxia, as well as cognitive impairment. Antemortem imaging studies showed findings of chronic cerebrovascular disease, with infarcts or white matter pathology.
CONCLUSIONS: This autopsy study of vascular CBS shows that, while rare, cerebrovascular pathology involving the frontal lobe, white matter tracts, basal ganglia, thalamus, and corticospinal tract can underlie clinical features suggestive of CBS. When neuroimaging suggests an alternative explanation, including chronic infarcts in critical regions, caution is merited in considering CBD as the underlying pathology.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebrovascular pathology; Corticobasal syndrome (CBS); Corticospinal tract degeneration; Vascular parkinsonism; Wallerian degeneration

Year:  2019        PMID: 31621626      PMCID: PMC7141792          DOI: 10.1016/j.parkreldis.2019.09.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  34 in total

1.  Deterioration of gait and balance over time: the effects of age-related white matter change--the LADIS study.

Authors:  Stefan H Kreisel; Christian Blahak; Hansjörg Bäzner; Domenico Inzitari; Leonardo Pantoni; Anna Poggesi; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Peter Langhorne; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Michael G Hennerici
Journal:  Cerebrovasc Dis       Date:  2013-07-06       Impact factor: 2.762

2.  Occurrence and temporal evolution of upper limb spasticity in stroke patients admitted to a rehabilitation unit.

Authors:  Keng H Kong; Jeanette Lee; Karen S Chua
Journal:  Arch Phys Med Rehabil       Date:  2012-01       Impact factor: 3.966

3.  Vascular corticobasal syndrome caused by unilateral internal carotid artery occlusion.

Authors:  Yosuke Miyaji; Kazuo Koyama; Takashi Kurokawa; Mutsumi Mitomi; Yume Suzuki; Yoshiyuki Kuroiwa
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-08-29       Impact factor: 2.136

4.  Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.

Authors:  K Gwinn-Hardy; N D Mehta; M Farrer; D Maraganore; M Muenter; S H Yen; J Hardy; D W Dickson
Journal:  Acta Neuropathol       Date:  2000-06       Impact factor: 17.088

Review 5.  Update on apraxia.

Authors:  Rachel Goldmann Gross; Murray Grossman
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

6.  [Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration?].

Authors:  A Kreisler; B Mastain; F Tison; G Fénelon; A Destée
Journal:  Rev Neurol (Paris)       Date:  2007-12       Impact factor: 2.607

Review 7.  The basal ganglia and apraxia.

Authors:  P P Pramstaller; C D Marsden
Journal:  Brain       Date:  1996-02       Impact factor: 13.501

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Authors:  Dietmar R Thal; Udo Rüb; Mario Orantes; Heiko Braak
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

10.  Wallerian degeneration after cerebral infarction: evaluation with sequential MR imaging.

Authors:  M J Kuhn; D J Mikulis; D M Ayoub; B E Kosofsky; K R Davis; J M Taveras
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

View more
  4 in total

1.  Cerebrovascular pathology and misdiagnosis of multiple system atrophy: An autopsy study.

Authors:  Shunsuke Koga; Shanu F Roemer; Philip W Tipton; Phillip A Low; Keith A Josephs; Dennis W Dickson
Journal:  Parkinsonism Relat Disord       Date:  2020-05-16       Impact factor: 4.402

Review 2.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

Review 3.  Neuropathology and emerging biomarkers in corticobasal syndrome.

Authors:  Shunsuke Koga; Keith A Josephs; Ikuko Aiba; Mari Yoshida; Dennis W Dickson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-06-13       Impact factor: 13.654

4.  Atypical parkinsonian syndromes in a North African tertiary referral center.

Authors:  Amina Nasri; Mouna Ben Djebara; Ikram Sghaier; Saloua Mrabet; Sabrina Zidi; Amina Gargouri; Imen Kacem; Riadh Gouider
Journal:  Brain Behav       Date:  2020-11-11       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.